ZyVersa Therapeutics, Inc.
ZVSA
$0.7151
$0.00711.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.42M | -2.40M | -2.76M | -2.83M | -13.34M |
| Total Depreciation and Amortization | -7.80K | 1.70K | 10.40K | 2.60K | -113.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 283.10K | 160.70K | 162.50K | 310.60K | 12.06M |
| Change in Net Operating Assets | -78.20K | 1.59M | 676.70K | -1.26M | -1.40M |
| Cash from Operations | -1.22M | -644.40K | -1.91M | -3.78M | -2.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.04M | 828.00K | 0.00 | 2.67M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -407.90K | -180.10K | -- | -- | -653.50K |
| Cash from Financing | 2.63M | 647.80K | 0.00 | 2.67M | 4.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.41M | 3.40K | -1.91M | -1.10M | 1.56M |